Journal article · 2009

The impact of COX-2 inhibitors for the treatment of early stage schizophrenia

Daniela Friebel, Daniel Fries, Judith Nürnberger, Nadja Ballmann, Michael Obermeier, Michael J Riedel, Norbert Müller

Brain Behavior and Immunity, 23, S23 · Published 1 July 2009 · DOI 10.1016/j.bbi.2009.05.062

View at the publisherCite this paper

In brief

“The impact of COX-2 inhibitors for the treatment of early stage schizophrenia” is a 2009 journal article by Daniela Friebel and 6 co-authors, published in Brain Behavior and Immunity. OpenAlex counts 0 citations as of 19 November 2026. The publisher's version is not open access, and OpenAlex records no free legal copy.

Citations
0
Authors
7

Cite this paper

Formatted from the catalogue record. Check names, capitals and page numbers against the paper before you submit.

APA 7

Friebel, D., Fries, D., Nürnberger, J., Ballmann, N., Obermeier, M., Riedel, M. J., & Müller, N. (2009). The impact of COX-2 inhibitors for the treatment of early stage schizophrenia. Brain Behavior and Immunity, 23, S23. https://doi.org/10.1016/j.bbi.2009.05.062

MLA 9

Friebel, Daniela, et al. “The impact of COX-2 inhibitors for the treatment of early stage schizophrenia.” Brain Behavior and Immunity, vol. 23, 2009, p. S23. https://doi.org/10.1016/j.bbi.2009.05.062.

Chicago

Friebel, Daniela, Daniel Fries, Judith Nürnberger, Nadja Ballmann, Michael Obermeier, Michael J Riedel, and Norbert Müller. 2009. “The impact of COX-2 inhibitors for the treatment of early stage schizophrenia.” Brain Behavior and Immunity 23: S23. https://doi.org/10.1016/j.bbi.2009.05.062.

Harvard

Friebel, D. et al. (2009) ‘The impact of COX-2 inhibitors for the treatment of early stage schizophrenia’, Brain Behavior and Immunity, 23, p. S23. doi:10.1016/j.bbi.2009.05.062.

IEEE

D. Friebel et al., “The impact of COX-2 inhibitors for the treatment of early stage schizophrenia,” Brain Behavior and Immunity, vol. 23, p. S23, 2009, doi: 10.1016/j.bbi.2009.05.062.

BibTeX

@article{friebel2009impact,
  title     = {{The impact of COX-2 inhibitors for the treatment of early stage schizophrenia}},
  author    = {Friebel, Daniela and Fries, Daniel and Nürnberger, Judith and Ballmann, Nadja and Obermeier, Michael and Riedel, Michael J and Müller, Norbert},
  journal   = {Brain Behavior and Immunity},
  year      = {2009},
  volume    = {23},
  pages     = {S23},
  doi       = {10.1016/j.bbi.2009.05.062},
  url       = {https://doi.org/10.1016/j.bbi.2009.05.062}
}

Download for a reference manager: BibTeX (.bib) · RIS for Zotero, Mendeley and EndNote (.ris)

Topic and keywords

Health Sciences › Medicine › Psychiatry and Mental health › Schizophrenia research and treatment

  • COX-2 inhibitors
  • early schizophrenia
  • nonsteroidal anti-inflammatory drugs
  • adverse drug reactions
  • schizophrenia pharmacotherapy
  • QTc prolongation
  • QT prolongation
  • cardiac arrhythmias

Work with this paper

Most-cited papers in Medicine

All highly cited Medicine papers

Questions about this paper

How do I cite this paper in APA style?

Friebel, D., Fries, D., Nürnberger, J., Ballmann, N., Obermeier, M., Riedel, M. J., & Müller, N. (2009). The impact of COX-2 inhibitors for the treatment of early stage schizophrenia. Brain Behavior and Immunity, 23, S23. https://doi.org/10.1016/j.bbi.2009.05.062

How many times has this paper been cited?

0 times, according to OpenAlex on 19 November 2026. Google Scholar and Scopus count different sets of sources, so their numbers differ.

Is this paper free to read?

OpenAlex records no free legal copy. Check your library's access, the authors' pages or a repository, or ask the corresponding author for a copy.

Who wrote this paper?

Daniela Friebel, Daniel Fries, Judith Nürnberger, Nadja Ballmann, Michael Obermeier, Michael J Riedel, Norbert Müller.

What is the DOI of this paper?

10.1016/j.bbi.2009.05.062, permanently at https://doi.org/10.1016/j.bbi.2009.05.062. Sign in and open it from this page.

Bibliographic data from OpenAlex (CC0), last checked 19 November 2026. ResearchGuru does not host this paper; once you are signed in, the links open it at the publisher or the repository that does.